norbuprenorphine has been researched along with Heroin Abuse in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alegakis, A; Belivanis, S; Kavvalakis, MP; Kovatsi, L; Mantsi, M; Tsatsakis, AM; Tzatzarakis, MN; Vakonaki, E; Vynias, D | 1 |
| Alegakis, A; Belivanis, S; Kovatsi, L; Liesivuori, J; Mantsi, M; Tsatsakis, AM; Tzatzarakis, MN; Vakonaki, E | 1 |
| Gerra, G; Marcheselli, C; Raggi, MA; Saracino, MA; Somaini, L; Zanchini, S | 1 |
| Allen, KR; Fox, EJ; Tetlow, VA | 1 |
| Abolencia, E; Agrawal, A; Barhate, R; Coulter, C; Moore, C; Morjana, N; Rodrigues, W; Soares, J; Taylor, C; Vincent, M; Wang, G; Zheng, YF | 1 |
| Averin, O; Choo, RE; Goodwin, RS; Huestis, MA; Jasinski, DR; Johnson, RE; Jones, HE; Schroeder, JR; Wilkins, DG | 1 |
| Cone, EJ; Fudala, PJ; Johnson, RE; Kuhlman, JJ; Levine, B | 1 |
2 trial(s) available for norbuprenorphine and Heroin Abuse
| Article | Year |
|---|---|
Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration.
Topics: Adult; Buprenorphine; Chromatography, Liquid; Female; Hair; Heroin Dependence; Humans; Infant; Infant, Newborn; Pregnancy; Pregnancy Complications; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tandem Mass Spectrometry; Tissue Distribution | 2007 |
Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.
Topics: Administration, Sublingual; Buprenorphine; Heroin Dependence; Humans; Male; Narcotic Antagonists; Substance Withdrawal Syndrome; Time Factors | 1998 |
5 other study(ies) available for norbuprenorphine and Heroin Abuse
| Article | Year |
|---|---|
Buprenorphine and nor-buprenorphine levels in head hair samples from former heroin users under Suboxone® treatment.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Chromatography, Liquid; Female; Hair; Heroin Dependence; Humans; Male; Mass Spectrometry; Naloxone; Narcotic Antagonists | 2014 |
Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy.
Topics: Adult; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Chromatography, Liquid; Female; Heroin Dependence; Humans; Male; Mass Spectrometry; Nails; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction | 2015 |
Combined liquid chromatography-coulometric detection and microextraction by packed sorbent for the plasma analysis of long acting opioids in heroin addicted patients.
Topics: Acetonitriles; Analgesics, Opioid; Buffers; Buprenorphine; Calibration; Chromatography, High Pressure Liquid; Electrochemical Techniques; Heroin Dependence; Humans; Limit of Detection; Methadone; Naloxone; Phosphates; Solid Phase Microextraction; Solvents | 2011 |
Quantitative analysis of buprenorphine and norbuprenorphine in urine using liquid chromatography tandem mass spectrometry.
Topics: Analgesics, Opioid; Buprenorphine; Chromatography, Liquid; Heroin Dependence; Humans; Mass Spectrometry | 2006 |
Development and GC-MS validation of a highly sensitive recombinant G6PDH-based homogeneous immunoassay for the detection of buprenorphine and norbuprenorphine in urine.
Topics: Analgesics, Opioid; Buprenorphine; Cross Reactions; Enzyme Multiplied Immunoassay Technique; Gas Chromatography-Mass Spectrometry; Glucosephosphate Dehydrogenase; Heroin Dependence; Humans; Recombinant Proteins; Reproducibility of Results; Substance Abuse Detection | 2007 |